For Authors BioPharm serves as the voice of an experienced mentor to the biopharmaceutical community. More than 20,000 U.S. readers count on BioPharm for practical information on developing and manufacturing pharmaceutical products through biotechnology. BioPharm's readers are also its authors. BioPharm does not pay for articles. Peer Review Members of the Editorial Advisory Board and other industry experts review all technical manuscripts.
Reviews are blind.
Readers, vendors, and product manufacturers are all best served when authors present their scientific and technical data and conclusions in a straightforward and neutral way. BioPharm readers know that the magazine's editors and reviewers insist on solid data to support an article's conclusions. Reviewers expect authors to resist the pressure to emphasize product names in their work, and they recommend rejection of manuscripts that look promotional. The editors will decide which format will most effectively showcase your article or submission. Review articles can highlight emerging technologies and update readers on issues critical to the biopharmaceutical industry.